| Added by | JPPOUGET |
|---|---|
| Group name | EquipeJPP |
| Item Type | Journal Article |
| Title | [Practical update of total dose compensation in case of temporary interruption of external radiotherapy in the COVID-19 pandemic context] |
| Creator | Azria et al. |
| Author | D. Azria |
| Author | C. Hennequin |
| Author | P. Giraud |
| Abstract | Overall treatment time is an important factor of local recurrence and indirectly of distant evolution, namely in case of protracted treatments. The current pandemic impacts on the duration of radiotherapy if patients under treatments and synchronously suffering from COVID-19. The models used to compensate the total dose in case of temporary treatment interruption are well known but it is of importance in that pandemic context to update and homogenize clinical practice in order to improve local control without increasing normal tissue complications. |
| Publication | Cancer Radiotherapie: Journal De La Societe Francaise De Radiotherapie Oncologique |
| Volume | 24 |
| Issue | 3 |
| Pages | 182-187 |
| Date | 2020-06 |
| Journal Abbr | Cancer Radiother |
| Language | fre |
| DOI | 10.1016/j.canrad.2020.04.001 |
| ISSN | 1769-6658 |
| Library Catalog | PubMed |
| Extra | Number: 3 PMID: 32307313 PMCID: PMC7146696 |
| Tags | Betacoronavirus, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Cell Proliferation, clinic, Compensation, Coronavirus Infections, COVID-19, Dose totale, Étalement, Female, first, first-last-coresponding, Humans, Lung Neoplasms, Male, Neoplasms, Pandemics, Pneumonia, Viral, Prostatic Neoplasms, Radiobiology, Radiothérapie, Radiotherapy, Radiotherapy Dosage, SARS-CoV-2, Time Factors, Total dose, Treatment duration, Uterine Cervical Neoplasms, Withholding Treatment |
| Date Added | 2023/11/23 - 12:48:32 |
| Date Modified | 2024/12/15 - 04:08:58 |
| Notes and Attachments | PubMed entry (Attachment) Texte intégral (Attachment) |
Institut de Recherche en Cancérologie de
